Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer.

Newcomb PA, Baron J, Cotterchio M, Gallinger S, Grove J, Haile R, Hall D, Hopper JL, Jass J, Le Marchand L, Limburg P, Lindor N, Potter JD, Templeton AS, Thibodeau S, Seminara D; Colon Cancer Family Registry.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2331-43. Epub 2007 Nov 2.

2.

Inheritance of a cancer-associated MLH1 germ-line epimutation.

Hitchins MP, Wong JJ, Suthers G, Suter CM, Martin DI, Hawkins NJ, Ward RL.

N Engl J Med. 2007 Feb 15;356(7):697-705.

3.

Unfavorable pathological characteristics in familial colorectal cancer with low-level microsatellite instability.

Kets CM, Hoogerbrugge N, Bodmer D, Willems R, Brunner HG, van Krieken JH, Ligtenberg MJ.

Mod Pathol. 2006 Dec;19(12):1624-30. Epub 2006 Sep 15.

4.

Cancer statistics, 2006.

Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ.

CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30.

5.

Familial risk of colon and rectal cancer in Iceland: evidence for different etiologic factors?

Stefansson T, Moller PH, Sigurdsson F, Steingrimsson E, Eldon BJ.

Int J Cancer. 2006 Jul 15;119(2):304-8.

6.

MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer.

Hitchins M, Williams R, Cheong K, Halani N, Lin VA, Packham D, Ku S, Buckle A, Hawkins N, Burn J, Gallinger S, Goldblatt J, Kirk J, Tomlinson I, Scott R, Spigelman A, Suter C, Martin D, Suthers G, Ward R.

Gastroenterology. 2005 Nov;129(5):1392-9.

PMID:
16285940
7.

Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).

Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Nakagawa H, Sotamaa K, Prior TW, Westman J, Panescu J, Fix D, Lockman J, Comeras I, de la Chapelle A.

N Engl J Med. 2005 May 5;352(18):1851-60.

8.

Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.

Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, Gallinger S, Bapat B, Aronson M, Hopper J, Jass J, LeMarchand L, Grove J, Potter J, Newcomb P, Terdiman JP, Conrad P, Moslein G, Goldberg R, Ziogas A, Anton-Culver H, de Andrade M, Siegmund K, Thibodeau SN, Boardman LA, Seminara D.

JAMA. 2005 Apr 27;293(16):1979-85.

9.

Low microsatellite instability is associated with poor prognosis in stage C colon cancer.

Kohonen-Corish MR, Daniel JJ, Chan C, Lin BP, Kwun SY, Dent OF, Dhillon VS, Trent RJ, Chapuis PH, Bokey EL.

J Clin Oncol. 2005 Apr 1;23(10):2318-24.

PMID:
15800322
10.

Low level microsatellite instability may be associated with reduced cancer specific survival in sporadic stage C colorectal carcinoma.

Wright CM, Dent OF, Newland RC, Barker M, Chapuis PH, Bokey EL, Young JP, Leggett BA, Jass JR, Macdonald GA.

Gut. 2005 Jan;54(1):103-8.

11.

Lynch syndrome (HNPCC) and microsatellite instability.

Umar A.

Dis Markers. 2004;20(4-5):179-80. Review. No abstract available.

12.

Familial risk for colorectal cancers are mainly due to heritable causes.

Hemminki K, Chen B.

Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1253-6.

13.

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Rüschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, Barrett JC, Freedman AN, Srivastava S.

J Natl Cancer Inst. 2004 Feb 18;96(4):261-8.

14.

Testing guidelines for hereditary non-polyposis colorectal cancer.

Umar A, Risinger JI, Hawk ET, Barrett JC.

Nat Rev Cancer. 2004 Feb;4(2):153-8. doi: 10.1038/nrc1278. Review. No abstract available.

PMID:
14964310
15.

Frequency of loss of hMLH1 expression in colorectal carcinoma increases with advancing age.

Kakar S, Burgart LJ, Thibodeau SN, Rabe KG, Petersen GM, Goldberg RM, Lindor NM.

Cancer. 2003 Mar 15;97(6):1421-7.

16.

Does MSI-low exist?

Tomlinson I, Halford S, Aaltonen L, Hawkins N, Ward R.

J Pathol. 2002 May;197(1):6-13. Review.

PMID:
12081205
17.

Low-level microsatellite instability in most colorectal carcinomas.

Laiho P, Launonen V, Lahermo P, Esteller M, Guo M, Herman JG, Mecklin JP, Järvinen H, Sistonen P, Kim KM, Shibata D, Houlston RS, Aaltonen LA.

Cancer Res. 2002 Feb 15;62(4):1166-70.

18.

Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors.

Lindor NM, Burgart LJ, Leontovich O, Goldberg RM, Cunningham JM, Sargent DJ, Walsh-Vockley C, Petersen GM, Walsh MD, Leggett BA, Young JP, Barker MA, Jass JR, Hopper J, Gallinger S, Bapat B, Redston M, Thibodeau SN.

J Clin Oncol. 2002 Feb 15;20(4):1043-8.

PMID:
11844828
19.

Low-level microsatellite instability occurs in most colorectal cancers and is a nonrandomly distributed quantitative trait.

Halford S, Sasieni P, Rowan A, Wasan H, Bodmer W, Talbot I, Hawkins N, Ward R, Tomlinson I.

Cancer Res. 2002 Jan 1;62(1):53-7.

20.

Biological significance of microsatellite instability-low (MSI-L) status in colorectal tumors.

Jass JR, Young J, Leggett BA.

Am J Pathol. 2001 Feb;158(2):779-81. No abstract available.

Supplemental Content

Support Center